Insights

Market commentary and guides

  • Brambles – Buy Signal (Valuation Support)

    We’ve been buying BXB and selling covered calls at $11 into May as a relatively defensive income play.    

  • James Hardie

    Shares of James Hardie have opened over 3% lower on an announcement that a weaker-than-expected December quarter has forced the company to cut earnings guidance.…

  • Tabcorp – Value Emerging

      Tabcorp is a relatively defensive income opportunity for portfolios, with earnings supported by potential synergy savings after the Tatts integration. The company continues to progress…

  • Tabcorp Half-Yearly Result

    Shares of Tabcorp have opened 3.5% lower as the betting company posted a 5% rise in half-yearly profits. The firm reported an interim dividend…

  • Boral – FY18 Earnings Review

    We thought it worthwhile to review the earnings outlook for Boral, post the acquisition of the Headwaters Group. In FY18 revenue grows to $6.2b,…

  • Ansell – Buy Signal

    Ansell has purchased Nitritex, a UK-based manufacturer of premium clean-room and healthcare Life Sciences consumables. The deal is relatively small at US$60m and will…

  • Tabcorp – 2nd of February

    Tabcorp reports earnings on the 2nd of February. We assume Tatts merger is completed by middle of this year and generates cost savings post…

  • Sonic Healthcare – Buy Signal

    SHL has strengthened its German footprint with the purchase of two laboratories from Medical Laboratory Bremen for A$90 million. The deal is EPS accretive…

  • AGL Outlook

    Several market commentators have focused on AGL as an Utility Stock ready to make a strong move higher; we aren’t as confident. While the…

  • QBE Higher On Merger Talks

    Shares of QBE have jumped over 5% in early trade, posting a new 15-month high of 12.97, on rumors that the firm was in…